Text Size A A A

Sun Pharma and Almirall enter into a License Agreement for Tildrakizumab in Europe for Psoriasis

Tell a Friend Print Home » Sun Pharma and Almirall enter into a License Agreement for Tildrakizumab in Europe for Psoriasis
Released Date: 
Wednesday, July 27, 2016

Category:

ishtml: